Earnings summaries and quarterly performance for Turning Point Brands.
Executive leadership at Turning Point Brands.
Graham A. Purdy
Detailed
Chief Executive Officer
CEO
Andrew Flynn
Detailed
Chief Financial Officer
Brittani N. Cushman
Detailed
Senior Vice President, General Counsel and Secretary
David E. Glazek
Detailed
Executive Chairman
Lorenzo De Plano
Detailed
Chief of Strategy
Summer Frein
Detailed
Senior Vice President, Chief Revenue Officer
Board of directors at Turning Point Brands.
Research analysts who have asked questions during Turning Point Brands earnings calls.
Eric Des Lauriers
Craig-Hallum Capital Group LLC
6 questions for TPB
Also covers: AGFY, COCO, CURLF +17 more
Aaron Grey
Alliance Global Partners
5 questions for TPB
Also covers: AFCG, AGFY, CGC +22 more
Ian Zaffino
Oppenheimer & Co. Inc.
5 questions for TPB
Also covers: ACA, ALSN, ARMK +18 more
Nick Anderson
ROTH MKM
4 questions for TPB
Also covers: ISPR
Gerald Pascarelli
Needham & Company
3 questions for TPB
Also covers: AGFY, CELH, COCO +8 more
Nicholas Anderson
Roth MKM
2 questions for TPB
Also covers: ISPR, TLRY
Michael Legg
Ladenburg Thalmann & Co. Inc.
1 question for TPB
Also covers: AQMS, CPSH, GOEV +3 more
Recent press releases and 8-K filings for TPB.
Turning Point Brands Amends At-The-Market Sales Agreement
TPB
- Turning Point Brands, Inc. entered into an at-the-market sales agreement on December 13, 2024, with B. Riley Securities, Inc. and Barclays Capital Inc. for the issuance and sale of its common stock.
- The original prospectus supplement permitted the company to offer and sell shares of Common Stock with an aggregate offering price of up to $100,000,000.
- As of November 5, 2025, the company has sold shares under this agreement for gross proceeds of $99,999,137.
- An amendment has been filed to increase the aggregate dollar amount of Common Stock available to be sold by an additional $200,000,000, exclusive of the amount already sold.
Nov 5, 2025, 10:12 PM
Turning Point Brands Reports Strong Q3 2025 Results and Raises Full-Year Guidance
TPB
Earnings
Guidance Update
New Projects/Investments
- Turning Point Brands reported strong financial results for Q3 2025, with net sales increasing 31.2% year-over-year to $119 million and adjusted EBITDA rising 17.2% to $31.3 million.
- The company experienced exceptional growth in its Modern Oral segment (628%) and significant growth in the Stoker’s segment (80.8%).
- Turning Point Brands raised its full-year 2025 adjusted EBITDA guidance to $115-$120 million and its Modern Oral sales forecast to $125-$130 million.
- The company raised $97.5 million through an at-the-market offering to fund expansion, particularly in the Modern Oral segment, with its first U.S. white pouch production lines expected to qualify in early 2026.
- Turning Point Brands ended Q3 2025 with a strong balance sheet, including $201.2 million in cash and net debt of $98.8 million, and declared a consistent quarterly dividend of $0.075 per share.
Nov 5, 2025, 9:49 PM
Turning Point Brands Reports Strong Q3 2025 Results and Raises Full-Year Guidance
TPB
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Turning Point Brands reported strong Q3 2025 results, with revenue increasing 31% to $119 million and Adjusted EBITDA up 17% to $31.3 million.
- The company raised its full-year 2025 Adjusted EBITDA guidance to a range of $115-$120 million (up from $110-$114 million) and its total modern oral sales guidance to $125-$130 million (up from $100-$110 million).
- Modern oral nicotine pouch sales, including Fre and On!, saw substantial growth, increasing 628% year over year to $36.7 million in Q3 2025.
- During the quarter, the company raised $100 million in gross proceeds through an at-the-market offering at an average share price of $98.59 to support modern oral growth initiatives.
- TPB is making significant investments in its modern oral business, including expanding its sales force and expecting to qualify its first U.S. white pouch production lines in the first half of 2026.
Nov 5, 2025, 1:30 PM
Turning Point Brands Announces Third Quarter 2025 Results
TPB
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Turning Point Brands reported consolidated net sales of $119.0 million for Q3 2025, an increase of 31.2% year-over-year.
- Modern Oral net sales significantly grew by 627.6% year-over-year to $36.7 million, representing 30.8% of total company net sales.
- Q3 2025 Adjusted EBITDA increased 17.2% to $31.3 million, with Diluted EPS at $1.13 and Adjusted Diluted EPS at $1.27.
- The company raised its 2025 Adjusted EBITDA guidance to $115.0 \u2013 120.0 million and its full-year Modern Oral sales guidance to $125.0 \u2013 130.0 million.
Nov 5, 2025, 12:55 PM
Turning Point Brands Announces Third Quarter 2025 Results and Increased Guidance
TPB
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Turning Point Brands reported Q3 2025 consolidated net sales of $119.0 million, an increase of 31.2% year-over-year, significantly boosted by a 627.6% year-over-year surge in Modern Oral net sales to $36.7 million.
- For Q3 2025, Adjusted EBITDA increased 17.2% to $31.3 million, with diluted EPS at $1.13 and Adjusted Diluted EPS at $1.27.
- The company raised its full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) and its Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million).
Nov 5, 2025, 12:30 PM
Quarterly earnings call transcripts for Turning Point Brands.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
Let Fintool AI Agent track Turning Point Brands's earnings for you
Get instant analysis when filings drop